Bacteria-Based MR Molecular Imaging of Tumor Oxygenation

基于细菌的肿瘤氧合 MR 分子成像

基本信息

  • 批准号:
    6845062
  • 负责人:
  • 金额:
    $ 24.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-15 至 2005-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Tumor oxygenation plays a critical important role in tumor growth, invasion, and therapy. Tumor tissues usually produce endothelial growth factors (such as VEGF) that stimulate new growth of blood vessels to meet the high nutrient demands of the fast growing tumor cells. Tumor cells have different characteristics as a function of their distance from the blood vessels and can be typified by their degree of oxygenation: the most viable cells are well perfused and oxygenated, the hypoxic cells are poorly oxygenated, and the necrotic center contain dead cells as a result of oxygen deprivation. These tumor cells have different genetic and molecular characteristics and possibly different response to various therapeutic interventions including radiation and chemotherapy. Currently, invasive microelectrode approach is used as a gold standard measurement of tumor oxygenation. Crucial is the selection of the sampling locations with this method since artifacts may be generated when multiple electrode measurements are required around the same tissue location. We propose a novel molecular imaging approach to map tumor oxygenation in vivo based on an attenuated strain of Salmonella typhimurium that selectively accumulates and proliferate in tumor tissues. Myoglobin will be genetically engineered into the Salmonella bacteria as an oxygen sensor. Since Salmonella can penetrate into the hypoxic areas in the tumor, the method will give a full mapping of tumor oxygenation. In this R21 proposal, we will develop a novel molecular imaging methods to map tumor oxygen tension in murine tumor models using the attenuated Salmonella typhimurium strain that over-expresses the oxygen sensing protein myoglobin. Deoxymyoglobin can be measured directly in vivo using a signature peak at -80 ppm in the proton spectroscopy for oxygen tension calculations, or indirectly in high-resolution tumor tissue water imaging whereas deoxymyoglobin functions as a relaxation contrast reagent. This novel measurement of tumor oxygen tension will be applied to observe the primary and metastasized tumors. The methods will have numerous applications in preclinical development of anticancer drugs considering physiological parameters in a particular tumor microenvironment. Since Salmonella typhimurium is currently in phase I clinical trials, the project may have a major impact in the future diagnosis of both primary tumors and distant metastasis, as well as therapeutic planning and monitoring of the cancer clinical outcomes.
描述(由申请人提供):肿瘤氧合在肿瘤生长、侵袭和治疗中起着至关重要的作用。肿瘤组织通常产生内皮生长因子(如VEGF),其刺激新血管的生长以满足快速生长的肿瘤细胞的高营养需求。肿瘤细胞具有不同的特征,作为它们与血管的距离的函数,并且可以通过它们的氧合程度来代表:最有活力的细胞被良好地灌注和氧合,缺氧细胞氧合不良,并且坏死中心包含由于氧剥夺而死亡的细胞。这些肿瘤细胞具有不同的遗传和分子特征,并且可能对各种治疗干预(包括放射和化学疗法)具有不同的反应。目前,有创微电极方法被用作测量肿瘤氧合的金标准。关键是使用这种方法选择采样位置,因为当需要在同一组织位置周围进行多个电极测量时可能会产生伪影。我们提出了一种新的分子成像方法来映射肿瘤氧合在体内的基础上减毒鼠伤寒沙门氏菌,选择性地积累和增殖的肿瘤组织。肌红蛋白将被基因工程改造成沙门氏菌作为氧传感器。由于沙门氏菌可以渗透到肿瘤中的缺氧区域,因此该方法将给出肿瘤氧合的完整映射。在这个R21提案中,我们将开发一种新的分子成像方法,使用过表达氧敏感蛋白肌红蛋白的减毒鼠伤寒沙门氏菌菌株来绘制小鼠肿瘤模型中的肿瘤氧张力。脱氧肌红蛋白可以在体内使用质子光谱中约80 ppm处的特征峰直接测量,用于氧张力计算,或者在高分辨率肿瘤组织水成像中间接测量,而脱氧肌红蛋白用作弛豫造影剂。这种新的测量肿瘤氧分压将被应用于观察原发性和转移性肿瘤。该方法将在考虑特定肿瘤微环境中的生理参数的抗癌药物的临床前开发中具有许多应用。由于鼠伤寒沙门氏菌目前处于I期临床试验阶段,该项目可能对原发性肿瘤和远处转移的未来诊断以及治疗计划和癌症临床结果的监测产生重大影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

QIUHONG HE其他文献

QIUHONG HE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('QIUHONG HE', 18)}}的其他基金

Fast 3D MR Spectroscopic Imaging of Human Breast Cancer
人类乳腺癌的快速 3D MR 光谱成像
  • 批准号:
    6920873
  • 财政年份:
    2005
  • 资助金额:
    $ 24.64万
  • 项目类别:
Fast 3D MR Spectroscopic Imaging of Human Breast Cancer
人类乳腺癌的快速 3D MR 光谱成像
  • 批准号:
    7436157
  • 财政年份:
    2005
  • 资助金额:
    $ 24.64万
  • 项目类别:
Fast 3D MR Spectroscopic Imaging of Human Breast Cancer
人类乳腺癌的快速 3D MR 光谱成像
  • 批准号:
    7282039
  • 财政年份:
    2005
  • 资助金额:
    $ 24.64万
  • 项目类别:
Fast 3D MR Spectroscopic Imaging of Human Breast Cancer
人类乳腺癌的快速 3D MR 光谱成像
  • 批准号:
    7591135
  • 财政年份:
    2005
  • 资助金额:
    $ 24.64万
  • 项目类别:
Fast 3D MR Spectroscopic Imaging of Human Breast Cancer
人类乳腺癌的快速 3D MR 光谱成像
  • 批准号:
    7070654
  • 财政年份:
    2005
  • 资助金额:
    $ 24.64万
  • 项目类别:
Bacteria-Based MR Molecular Imaging of Tumor Oxygenation
基于细菌的肿瘤氧合 MR 分子成像
  • 批准号:
    6800839
  • 财政年份:
    2003
  • 资助金额:
    $ 24.64万
  • 项目类别:
IN VIVO PROTON MRS DETECTION OF MALIGNANT BREAST CANCER
恶性乳腺癌的体内质子 MRS 检测
  • 批准号:
    6084604
  • 财政年份:
    2000
  • 资助金额:
    $ 24.64万
  • 项目类别:
IN VIVO PROTON MRS DETECTION OF MALIGNANT BREAST CANCER
恶性乳腺癌的体内质子 MRS 检测
  • 批准号:
    6377069
  • 财政年份:
    2000
  • 资助金额:
    $ 24.64万
  • 项目类别:
IN VIVO PROTON MRS DETECTION OF MALIGNANT BREAST CANCER
恶性乳腺癌的体内质子 MRS 检测
  • 批准号:
    6400793
  • 财政年份:
    2000
  • 资助金额:
    $ 24.64万
  • 项目类别:
THREE-DIMENSIONAL ELECTROPHORETIC NMR OF MIXED PROTEINS
混合蛋白质的三维电泳核磁共振
  • 批准号:
    6581142
  • 财政年份:
    1997
  • 资助金额:
    $ 24.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了